Trending Now
Could Cosmos Holdings (COSM) Become a Major Disruptor in an Estimated...
The health scare has only accelerated the global demand for medication. In fact, according to Fortune Business Insights, in 2020, the health...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Trevena Inc (NASDAQ:TRVN) Collaborates with Imperial College London to Conduct a...
The presence of COVID-19 continues to be one of the trending topics across the world. However, efforts to bring forth a potential vaccine are...
MAKE IT MODERN
LATEST REVIEWS
Tauriga Sciences Inc (OTCMKTS:TAUG) Blasts Onto the Radar
One stock that could pop onto a lot of radars this week is Tauriga Sciences Inc (OTCMKTS:TAUG). The company is a revenue generating, diversified...
MAKE IT MODERN
PERFORMANCE TRAINING
Incyte (NASDAQ:INCY) Enters Agreement With Nimble Therapeutics For the discovery of Peptide Therapies
Incyte (NASDAQ:INCY) has entered a strategic collaboration with Nimble Therapeutics Inc. for the discovery of first in class peptide therapies in different disease areas.
Nimble...
Markets in precarious situation heading into volatility
The markets are in a precarious situation right now. We are right off all-time highs and the corona virus is spreading.
Anavex Life Sciences Corp (NASDAQ:AVXL) Receives SAS Approval For ANAVEX2-73 To Treat Patients With...
The Australian GDH (Government Department of Health) – TGA (Therapeutic Goods Administration) granted SAS (Special Access Scheme) approval Anavex2-73 of Anavex Life Sciences Corp...
Dyne Therapeutics Inc. (NASDAQ: DYN) Receives Clinical Hold From FDA Regarding IND for...
Dyne Therapeutics Inc. (NASDAQ: DYN) has announced that the US FDA has put a clinical hold on its Investigational New Drug application...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Receives CE mark And Marketing Approval For COVISTIX from...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) has received an official CE Mark for COVISTIX and marketing approval from Federal Agency for Medicines and Health Products...
MAKE IT MODERN
